现代脂质三联治疗ppt课件

上传人:bin****86 文档编号:55900760 上传时间:2018-10-08 格式:PPT 页数:45 大小:710KB
返回 下载 相关 举报
现代脂质三联治疗ppt课件_第1页
第1页 / 共45页
现代脂质三联治疗ppt课件_第2页
第2页 / 共45页
现代脂质三联治疗ppt课件_第3页
第3页 / 共45页
现代脂质三联治疗ppt课件_第4页
第4页 / 共45页
现代脂质三联治疗ppt课件_第5页
第5页 / 共45页
点击查看更多>>
资源描述

《现代脂质三联治疗ppt课件》由会员分享,可在线阅读,更多相关《现代脂质三联治疗ppt课件(45页珍藏版)》请在金锄头文库上搜索。

1、现代脂质三联治疗,Introduction,Part I,Efficacy - The Power to Reach Target,Key Factor: + Differentiators:LDL Reduction TGHDLLDL/HDL RatioThe Lipid Triad,The LDL/HDL Ratio - Our Strength, Our Story!,A new perception of efficacy,LDL,HDL,Additional risk factor, especially in diabetics,The Lipid Triad - Overview

2、,TG,The Lipid Triad,The Ratio,The Lipid Triad and Strategic Rationale,Part II,No scientific evidence Evidence contradicting this statementA marketing hypothesis to build their LDL storyCreating the perception of the statin with the strongest efficacy,The lower. .the better?,Its logical,Its measurabl

3、e,Its practicable,The Lipid Triad - The GPs Perspective,HDL,LDL,Supporting Data from Landmark Studies,Part III,121086420,% Mortality,Placebo Q1 Q2 Q3 Q4(low HDL-increase) (high HDL-increase),4S - Study,CAD Mortality per Quartiles of Increases in HDL-Cholesterol,KJEKSHUS J & PEDERSEN T (unpublished),

4、HDL Intervention Trial (VA-HIT),RUBINS HB et al. New Engl J Med 1999; 341:410,0,6,-31,-4,-35,-30,-25,-20,-15,-10,-5,0,5,10,Cholesterol LDL-C HDL-C Triglycerides,Percent change compared to placebo at 1 year,Secondary Prevention in 2531 men with low HDL-C & LDL-C showed a 22% reduction in combined fat

5、al and non-fatal MI,HDL - Cholesterol as Risk Factor for CHD,LRC - CPPT (Placebo),MRFIT (usual care),Incidence rate of CHD,Incidence rate of CHD,12 10 8 6 4 2 0,100 130 160 190,GORDON DJ et al. Circulation 1989; 79: 8 - 15.,HDL - C mg / dl 65 55 45 35,LDL - Cholesterol mg / dl,LDL - Cholesterol mg /

6、 dl,12 10 8 6 4 2 0,100 130 160 190,0,0.5,1,1.5,2,2.5,3,Framingham Heart Study,CAD risk as a function of LDL-C and HDL-Cin men (50 to 70 y),CASTELLI WP. Am J Cardiol 1998; 82:60-65,220 160 100,85,65,45,25,HDL-Cholesterol (mg/dl),LDL Cholesterol (mg/dL),0,2,4,6,8,10,12,14,16,LDL5,HDL=1.08,HDL1.08,LDL

7、/HDL5,Incidence of cardiac events,(per 1000 person-years),Gemfibrozil,Placebo,LDL-C Tertiles (mmol/L),HDL-C Tertiles (mmol/L),LDL-C/HDL-C Tertiles,Incidence for cardiac events vs lipid parameter,Helsinki Heart Study,MANNINEN V, Leena T, Koskinen P et al. Circulation 1992; 85: 37-45,AFCAPS/TEXCAPS,Ap

8、o B/A1 Tertiles,LDL-C/HDL-C Tertiles,1.6,1.4,1.2,1,0.8,0.6,0.4,0.2,0,1.6,1.4,1.2,1,0.8,0.6,0.4,0.2,0,Event Rate per 100 Patient-Years of Risk,Event Rate per 100 Patient-Years of Risk, 0.8889,0.8898- 1.0205,1.0252, 3.7742,3.7744-4.4096,4.4101,GOTTO A et al. Circulation 2000; 101: 477-484,LDL/HDL Rati

9、o as Therapeutic Success,Placebo,Statin,24,116,31,245,0,50,100,150,200,250,300, 5,LDL / HDL - Ratio,Triglycerides = 200 mg/dl,CAD cases per 1,000 subjects in 6 years,ASSMANN G and SCHULTE H; Am J Cardiol 1992; 70: 733-737,Incidence of CAD vs LDL/HDL ratio by TG level (n = 4559),PROCAM Heart Study,0,

10、50,100,150,200,250,300,3,4,5,6,7,LDL/HDL ratio,CHD Incidence/1000 in 6 years,CHD risk according to LDL/HDL ratio at baseline,ASSMANN G; Lipid Metabolism Disorders and CHD; MMV Medizin Verlag, 1993: 43,5,High CHD risk,Medium CHD risk,Low CHD risk,3-5,3,PROCAM Heart Study,Mean values for developing at

11、herosclerotic CHD within 6 years,Variable CHD Development No CHD Development (n = 186) (n = 4221)TC (mg/dl) 251.8 222.9 HDL-C (mg/dl) 39.5 45.2 LDL-C (mg/dl) 176.2 147.1 LDL/HDL ratio 4.72 3.4 TG (mg/dl) 163.0 134.5,ASSMANN G; Lipid Metabolism Disorders and CHD; MMV Medizin Verlag, 1993: 41,PROCAM H

12、eart Study,Predictive value of risk factors for developing atherosclerotic CHD within 6 years,Variable Risk Ratio Predictive Power % TG 200 mg/dl 2.3 7.5 TC 250 (mg/dl) 2.8 8.3 LDL-C 195 (mg/dl) 3.7 12.0 LDL-C 155 (mg/dl) 3.3 7.1 HDL-C 35 (mg/dl) 3.9 11.0 LDL/HDL ratio 5 6.4 16.5,ASSMANN G; Lipid Me

13、tabolism Disorders and CHD; MMV Medizin Verlag, 1993: 43,PROCAM Heart Study,HDL as CHD risk factor showed 186 events, in men aged 40 - 60 years (n = 4407),CHD Incidence per 1, 000 in 6 years,0,20,40,60,80,100,120,140,160, 35 35 - 55 55,HDL-C (mg/dL),110,30,21,ASSMANN G; Lipid Metabolism Disorders an

14、d CHD; MMV Medizin Verlag, 1993: 59,PROCAM Heart Study,LDL as CHD risk factor showed 177 events in men aged 40 - 60 years, ( n = 4263),CHD Incidence per 1, 000 in 6 years,0,20,40,60,80,100,120,140, 135 135 - 154 155 - 195 195,LDL-C (mg/dL),54,30,16,31,120,ASSMANN G; Lipid Metabolism Disorders and CH

15、D; MMV Medizin Verlag, 1993: 60,PROCAM Heart Study,Expert Opinions,Part IV,The Lipid Triad - Expert Comments,AHA, November 1999“Evaluating the risk on the bases of LDL alone, is naive”Valentin Fuster, Mount Sinai Medical Center, New York“The LDL/HDL ratio is a much stronger predictor for the CHD risk than LDL alone”Paul Ridker, Brigham Institute for Womens Hospital, Boston,

展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 办公文档 > PPT模板库 > 其它

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号